Marcus Theatres President Holds 57,000+ Stock Options, Reports New Position

[Form 3/A] The Marcus Corporation Amended Initial Statement of Beneficial Ownership

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

3/A

Rhea-AI Filing Summary

This Form 3/A is an amended initial statement of beneficial ownership for Mark A. Gramz, President of Marcus Theatres Corporation, filed for The Marcus Corporation (NYSE: MCS). The amendment, dated June 25, 2025, updates the original filing from August 14, 2023.

Key beneficial ownership details:

Direct Common Stock Holdings: 1,271 shares directly owned, plus 6,700 restricted shares granted March 1, 2023 with staged vesting
Indirect Holdings: 4,944.63 shares through 401(k) Plan (newly reported in this amendment)
Stock Options: Multiple tranches totaling 57,190 shares with exercise prices ranging from $12.71 to $41.90 and expiration dates from 2024 to 2033

The filing includes detailed vesting schedules for restricted stock (50% after 2 years, 100% after 4 years) and stock options (varying between 4-5 year vesting periods with different percentage milestones).

06/25/2025 - 11:54 AM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gramz Mark A

(Last)

(First)

(Middle)

100 EAST WISCONSIN AVENUE

SUITE 1900

(Street)

MILWAUKEE

53202-4125

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/31/2023

3. Issuer Name and Ticker or Trading Symbol
MARCUS CORP [ MCS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Pres., Marcus Theatres Corp*

5. If Amendment, Date of Original Filed (Month/Day/Year)
08/14/2023

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,271	D
Common Stock	6,700⁽¹⁾	D
Common Stock	4,944.6253⁽²⁾	I	By 401K Plan

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽³⁾	07/29/2024	Common Stock	700	$18.34	D
Stock Option (Right to Buy)	⁽³⁾	07/28/2025	Common Stock	3,500	$20.26	D
Stock Option (Right to Buy)	⁽³⁾	02/28/2026	Common Stock	2,040	$18.68	D
Stock Option (Right to Buy)	⁽³⁾	02/28/2027	Common Stock	3,500	$31.2	D
Stock Option (Right to Buy)	⁽⁴⁾	02/27/2028	Common Stock	3,500	$27	D
Stock Option (Right to Buy)	⁽⁴⁾	02/26/2029	Common Stock	3,500	$41.9	D
Stock Option (Right to Buy)	⁽⁴⁾	02/25/2030	Common Stock	3,500	$28.88	D
Stock Option (Right to Buy)	⁽⁴⁾	05/08/2030	Common Stock	1,750	$12.71	D
Stock Option (Right to Buy)	⁽⁴⁾	03/09/2031	Common Stock	4,200	$21.84	D
Stock Option (Right to Buy)	⁽⁴⁾	03/08/2032	Common Stock	3,500	$17.04	D
Stock Option (Right to Buy)	⁽⁴⁾	03/07/2033	Common Stock	27,500	$15.99	D

Explanation of Responses:

1. Restricted stock granted March 1, 2023 vests as follows: 50% after 2nd anniversary of date of grant and 100% after 4th anniversary of date of grant.

2. Balance reflects the most current data available with regard to the reporting person's holdings in the 401(k) Plan. This amount was not previously reported on the Form 3 filed on August 14, 2023.

3. The options originally granted vest as follows: 40% after 2nd anniversary of the date of grant; 60% after 3rd anniversary; 80% after 4th anniversary; and 100% after 5 years.

4. The options originally granted vest as follows: 50% after 2nd anniversary of the date of grant; 75% after 3rd anniversary; and 100% after 4 years.

Remarks:

President, Marcus Theatres Corporation*

	/s/ Steven R. Barth, Attorney-in-Fact for Mark A. Gramz	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many shares of MCS common stock does Mark Gramz directly own?

Mark Gramz directly owns 7,971 shares of MCS common stock, consisting of 1,271 shares of common stock and 6,700 shares of restricted stock granted on March 1, 2023.

What stock options does Mark Gramz hold for MCS shares?

Mark Gramz holds multiple stock option grants totaling 57,190 shares, with exercise prices ranging from $12.71 to $41.90. His most recent grant was for 27,500 options on March 7, 2023, with an exercise price of $15.99.

What is the vesting schedule for Mark Gramz's MCS restricted stock granted in 2023?

The restricted stock granted on March 1, 2023 follows a two-tier vesting schedule: 50% vests after the second anniversary of the grant date, and 100% vests after the fourth anniversary of the grant date.

What position does Mark Gramz hold at Marcus Corporation (MCS)?

Mark Gramz serves as the President of Marcus Theatres Corporation, a division of The Marcus Corporation (MCS).

How many MCS shares does Mark Gramz hold in his 401(k) plan?

Mark Gramz holds 4,944.6253 shares of MCS common stock indirectly through his 401(k) plan, which was not previously reported on the original Form 3 filed on August 14, 2023.

AG真人官方

[Form 3/A] The Marcus Corporation Amended Initial Statement of Beneficial Ownership

FAQ

How many shares of MCS common stock does Mark Gramz directly own?

What stock options does Mark Gramz hold for MCS shares?

What is the vesting schedule for Mark Gramz's MCS restricted stock granted in 2023?

What position does Mark Gramz hold at Marcus Corporation (MCS)?

How many MCS shares does Mark Gramz hold in his 401(k) plan?

NYSE:MCS

MCS Rankings

MCS Latest News

MCS Latest SEC Filings

MCS Stock Data

AG真人官方

Trending News

[Form 3/A] The Marcus Corporation Amended Initial Statement of Beneficial Ownership

FAQ

How many shares of MCS common stock does Mark Gramz directly own?

What stock options does Mark Gramz hold for MCS shares?

What is the vesting schedule for Mark Gramz's MCS restricted stock granted in 2023?

What position does Mark Gramz hold at Marcus Corporation (MCS)?

How many MCS shares does Mark Gramz hold in his 401(k) plan?

NYSE:MCS

MCS Rankings

MCS Latest News

MCS Latest SEC Filings

MCS Stock Data